The novel combination of sirolimus and bortezomib prevents graft-versus-host disease but maintains the graft-versus-leukemia effect after allogeneic transplantation.
about
Sirolimus and post transplant Cy synergistically maintain mixed chimerism in a mismatched murine model.New perspectives on the use of mTOR inhibitors in allogeneic haematopoietic stem cell transplantation and graft-versus-host disease.Targeting the Canonical Nuclear Factor-κB Pathway with a High-Potency IKK2 Inhibitor Improves Outcomes in a Mouse Model of Idiopathic Pneumonia Syndrome.Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis.Bortezomib initiates endoplasmic reticulum stress, elicits autophagy and death in Echinococcus granulosus larval stage.
P2860
The novel combination of sirolimus and bortezomib prevents graft-versus-host disease but maintains the graft-versus-leukemia effect after allogeneic transplantation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The novel combination of sirol ...... er allogeneic transplantation.
@ast
The novel combination of sirol ...... er allogeneic transplantation.
@en
type
label
The novel combination of sirol ...... er allogeneic transplantation.
@ast
The novel combination of sirol ...... er allogeneic transplantation.
@en
prefLabel
The novel combination of sirol ...... er allogeneic transplantation.
@ast
The novel combination of sirol ...... er allogeneic transplantation.
@en
P2093
P2860
P1433
P1476
The novel combination of sirol ...... ter allogeneic transplantation
@en
P2093
Belén Blanco
Carmen Herrero
Concepción Serrano
Consuelo del Cañizo
Cristina Calderon
José A Pérez-Simón
Luis Ignacio Sánchez-Abarca
Silvia Gutierrez-Cosio
Soraya Carrancio
Teresa Caballero-Velázquez
P2860
P304
P356
10.3324/HAEMATOL.2011.058677
P577
2012-04-24T00:00:00Z